AstraZeneca saw 18% revenue growth in 2024, boosted by key drugs and global innovation. See here to know why we recommend a ...

Steel Dynamics' strong balance sheet, ongoing capital returns, and strategic investments position it as a top opportunity.

New research finds AI systems still struggle with facts despite improvements; researchers doubt quick fixes for accuracy ...